Look for:

Our offer for

NOVARTIS AG


ISIN:
CH0012005267
WKN:
1200526
2024/04/11 21:31:49
Price
93.6375 USD
Difference -0.49% (-0.46)

General attributes

ISINCH0012005267
SymbolNOVN
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)171,556 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open93.80 USD
High94.25 USD
Low93.6375 USD
Close (prev. day)94.10 USD
VWAP93.925436 USD
Volume (pcs)4,584
Trading volume430,554.20
Number of trades6
Last size1,000

Futures and Options

Related Futures30
Related Options-

PDF Downloads

Company report: NOVARTIS AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/11 21:31:49
Price
93.6375 USD
Difference -0.49% (-0.46)

General attributes

ISINCH0012005267
SymbolNOVN
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)171,556 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open93.80 USD
High94.25 USD
Low93.6375 USD
Close (prev. day)94.10 USD
VWAP93.925436 USD
Volume (pcs)4,584
Trading volume430,554.20
Number of trades6
Last size1,000

Performance and Risk

6m1Y3Y
Perf (%)---
Perf (abs.)---
Beta0.800.910.79
Volatility14.5918.5418.90
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)93.8688 USD (18,719)
Ø price 30 days | Ø volume 30 days (pcs.)96.0330 USD (5,327)
Ø price 100 days | Ø volume 100 days (pcs.)100.1005 USD (27,382)
Ø price 250 days | Ø volume 250 days (pcs.)99.7770 USD (22,825)
YTD High | date109.0000 USD (2024/01/23)
YTD Low | date92.2800 USD (2024/04/03)
52 Weeks High | date109.0000 USD (2024/01/23)
52 Weeks Low | date90.9200 USD (2023/10/31)

All listings for NOVARTIS AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Stuttgart2019/06/2821:5880.10 EUR0.0411
SIX Swiss Exchange2024/04/1617:3085.00 CHF260.1915,366
London Stock Exchange European Trade Reporting2024/04/1617:2084.675 CHF1.1821
Hanover2019/06/2808:0180.10 EUR0.002
Hamburg2019/06/2814:0580.19 EUR0.084
Frankfurt2019/06/2819:5780.16 EUR0.1313
FINRA other OTC Issues2024/04/1121:3193.6375 USD0.436
Duesseldorf2019/06/2814:0880.18 EUR0.002
Berlin2019/06/2818:4580.40 EUR0.0016
BX Swiss2024/04/1618:0084.776 CHF0.057

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2284&ID_TYPE_IMAGE_LOGO=2

Contact Details

NOVARTIS AG
- -
Lichtstrasse 35 - 4056 Basel
Telefon: +41-61-324-11-11
Fax: +
E-mail: -

PDF Downloads

Company report: NOVARTIS AGPDF Download

Company Profile

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Members of Management Board

Vasant Narasimhan, M.D.Chairman of Managing Board
James E. BradnerMember of Executive Committee
Klaus MoosmayerMember of Executive Committee
Steffen LangMember of Executive Committee
Susanne SchaffertMember of Executive Committee
Harry KirschMember of Executive Committee
John Tsai, M.D.Member of Executive Committee
Karen L. HaleMember of Executive Committee
Marie-France TschudinMember of Executive Committee
Richard SaynorMember of Executive Committee
Rob KowalskiMember of Executive Committee
Robert WeltevredenMember of Executive Committee

Board of directors

Charles SawyersMember of the administrative board
Nancy AndrewsMember of the administrative board
Simon MoroneyMember of the administrative board
Ana de Pro GonzaloMember of the administrative board
Bridgette HellerMember of the administrative board
Daniel HochstrasserMember of the administrative board
Frans van HoutenMember of the administrative board
John YoungMember of the administrative board
Mary DohertyMember of the administrative board
Patrice BulaMember of the administrative board
Ton BüchnerMember of the administrative board
William WintersMember of the administrative board
Hans Jörg ReinhardtChairman of the administrative boar





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer